Promising mRNA Vaccine Combo Targets Melanoma: Moderna and Merck’s Breakthrough
*New York, December 15:* A breakthrough in cancer treatment emerges as an experimental mRNA vaccine, developed by Moderna, exhibits promising results in combating melanoma, the deadliest form of skin cancer.…










